| Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended template biopsy JS Jue, MP Barboza, NS Prakash, V Venkatramani, VR Sinha, N Pavan, ... Urology 105, 123-128, 2017 | 87 | 2017 |
| Impact of the COVID-19 Pandemic on the Urologist’s clinical practice in Brazil: a management guideline proposal for low-and middle-income countries during the crisis period A Carneiro, ML Wroclawski, B Nahar, A Soares, AP Cardoso, NJ Kim, ... International braz j urol 46, 501-510, 2020 | 74 | 2020 |
| Trends in utilization of robotic and open partial nephrectomy for management of cT1 renal masses M Alameddine, T Koru-Sengul, KJ Moore, F Miao, LF Sávio, B Nahar, ... European urology focus 5 (3), 482-487, 2019 | 50 | 2019 |
| Optimizing patient's selection for prostate biopsy: a single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer S Punnen, B Nahar, N Soodana-Prakash, T Koru-Sengul, R Stoyanova, ... PLoS One 13 (8), e0201384, 2018 | 49 | 2018 |
| Subcutaneous Leydig stem cell autograft: a promising strategy to increase serum testosterone H Arora, MSSR Zuttion, B Nahar, D Lamb, JM Hare, R Ramasamy Stem cells translational medicine 8 (1), 58-65, 2019 | 33 | 2019 |
| Prospective evaluation of focal high intensity focused ultrasound for localized prostate cancer B Nahar, A Bhat, IM Reis, N Soodana-Prakash, MF Becerra, D Lopategui, ... The Journal of urology 204 (3), 483-489, 2020 | 25 | 2020 |
| Does every minute of renal ischemia still count in 2019? Unlocking the chains of a flawed thought process over five decades B Nahar, A Bhat, DJ Parekh European urology focus 5 (6), 939-942, 2019 | 24 | 2019 |
| A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma—Analysis of a national cancer registry V Venkatramani, T Koru-Sengul, F Miao, B Nahar, NS Prakash, S Swain, ... Urologic Oncology: Seminars and Original Investigations 36 (3), 90. e9-90. e14, 2018 | 24 | 2018 |
| Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy B Nahar, T Koru-Sengul, F Miao, NS Prakash, V Venkatramani, A Gauri, ... World journal of urology 36, 393-399, 2018 | 18 | 2018 |
| Sociodemographic and survival disparities for histologic variants of bladder cancer. JS Jue, T Koru-Sengul, KJ Moore, F Miao, M Alameddine, B Nahar, ... The Canadian Journal of Urology 25 (1), 9179-9185, 2018 | 17 | 2018 |
| Metastatic renal cell carcinoma with level IV thrombus: contemporary management with complete response to neoadjuvant targeted therapy A Bhat, B Nahar, V Venkatramani, I Banerjee, ON Kryvenko, DJ Parekh Case reports in urology 2019, 2019 | 15 | 2019 |
| The 4Kscore predicts the grade and stage of prostate cancer in the radical prostatectomy specimen: results from a multi-institutional prospective trial S Punnen, B Nahar, NS Prakash, DD Sjoberg, SM Zappala, DJ Parekh European urology focus 3 (1), 94-99, 2017 | 13 | 2017 |
| Impact of plant-based diet on PSA level: data from the National Health and Nutrition Examination Survey A Mouzannar, M Kuchakulla, R Blachman-Braun, S Nackeeran, ... Urology 156, 205-210, 2021 | 12 | 2021 |
| Reclassification rates of patients eligible for active surveillance after the addition of magnetic resonance imaging-ultrasound fusion biopsy: an analysis of 7 widely used … B Nahar, A Katims, MP Barboza, NS Prakash, V Venkatramani, B Kava, ... Urology 110, 134-139, 2017 | 11 | 2017 |
| Changes in male sexuality after urologic cancer: a narrative review R Barros, LA Favorito, B Nahar, R Almeida Jr, R Ramasamy International braz j urol 49, 175-183, 2023 | 9 | 2023 |
| Current state of image-guided focal therapy for prostate cancer RR Tourinho-Barbosa, BJ Wood, AL Abreu, B Nahar, T Shin, S Guven, ... World journal of urology 39, 701-717, 2021 | 8 | 2021 |
| Focal therapy for localized prostate cancer: Where do we stand? B Nahar, DJ Parekh European urology focus 6 (2), 208-211, 2020 | 8 | 2020 |
| Heterogeneity in genomic risk assessment from tissue based prognostic signatures used in the biopsy setting and the impact of magnetic resonance imaging targeted biopsy S Punnen, R Stoyanova, D Kwon, IM Reis, N Soodana-Prakash, CR Ritch, ... The Journal of urology 205 (5), 1344-1351, 2021 | 7 | 2021 |
| Imaging for the selection and monitoring of men on active surveillance for prostate cancer MC Velasquez, NS Prakash, V Venkatramani, B Nahar, S Punnen Translational andrology and urology 7 (2), 228, 2018 | 7 | 2018 |
| What is the current role of partial nephrectomy for T2 tumors B Nahar, ML Gonzalgo Can J Urol 24, 8698-704, 2017 | 6 | 2017 |
